ENTERA BIO LTD (ENTX) Stock Cash Flow
NASDAQ:ENTX - Nasdaq - IL0011429839 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -3.22M | -9.54M | -8.89M | -13.07M | -12.19M | |||
| Depreciation Amortization | -2.00K | 46.00K | 56.00K | 60.00K | 50.00K | |||
| Income Taxes - Deferred | N/A | 14.00K | 29.00K | 170.00K | -220.00K | |||
| Change In Working Capital | 862.00K | 112.00K | -195.00K | -1.84M | 1.41M | |||
| Interest Paid | N/A | N/A | 18.00K | N/A | N/A | |||
| Taxes Paid | N/A | N/A | 0.00 | 170.00K | 0.00 | |||
| Other non cash items | 1.46M | 2.55M | 1.69M | 2.17M | 1.88M | |||
| OPERATING CASH FLOW | -912.00K | -6.82M | -7.31M | -12.50M | -9.06M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 6.00K | -3.00K | -17.00K | -50.00K | -20.00K | |||
| Other Investing Activity | N/A | N/A | 0.00 | -60.00K | N/A | |||
| INVESTING CASH FLOW | 6.00K | -3.00K | -17.00K | -100.00K | -20.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 11.71M | 4.80M | 6.62M | 10.00K | 25.38M | |||
| Other Financing Activity | N/A | -323.00K | -580.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 11.78M | 4.48M | 6.04M | 10.00K | 25.38M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | 10.87M | -2.35M | -1.29M | -12.59M | 16.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -912.00K | -6.82M | -7.31M | -12.50M | -9.06M | |||
| Capital Expenditure | 6.00K | -3.00K | -17.00K | -50.00K | -20.00K | |||
| FREE CASH FLOW | -906.00K | -6.82M | -7.33M | -12.55M | -9.08M | |||
All data in USD